Advertisement
Screener

Alpha Tau Medical Ltd. (DRTS) Graph

DRTS Revenue Flow

A current filed revenue breakdown could not be established from the retained filing evidence.

  • 2025-06-30: Research and development $14.18M; Income tax $164.00K; Net income -$18.80M.
  • 2024-06-30: Research and development $13.31M; Income tax $4.00K; Net income -$15.35M.
  • 2023-06-30: Research and development $12.26M; Income tax $47.00K; Net income -$16.88M.
  • 2022-06-30: Research and development $10.68M; Income tax $8.00K; Net income -$27.74M.

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 6 month

Period endResearch and developmentIncome taxNet income
2025-06-30$14.18M$164.00K-$18.80M
2024-06-30$13.31M$4.00K-$15.35M
2023-06-30$12.26M$47.00K-$16.88M
2022-06-30$10.68M$8.00K-$27.74M

Revenue and expense 12 month

Period endResearch and developmentIncome taxNet income
2025-12-31$32.06M$121.00K-$42.63M
2024-12-31$27.02M$6.00K-$31.75M
2023-12-31$26.42M$16.00K-$29.16M
2022-12-31$20.89M$20.00K-$33.76M
2021-12-31$11.45M$7.00K-$27.27M
2020-12-31$7.54M$158.00K-$8.88M
2019-12-31$6.64M-$146.00K-$8.37M